Fetal Spiral Electrode, Model No. 9898 031 37631
FDA Recall Z-1250-2019 · Posted None
Advertisement
Recalling FirmPhilips North America, LLC
Recall StatusTerminated
Product CodeHGP
Date Initiated2019-01-25
Date Terminated2020-12-08
Product Quantity1,971,925 (78,877 boxes)
Reason for Recall
During use of the Philips FSE, it is possible for the metal electrode tip to break off and remain in the scalp of the newborn following labor and delivery.
Firm Action
On January 25, 2019, the firm distributed Customer Information Medical Device Correction letters to affected customers. The letter informed customers that there was an increase in complaints regarding the Fetal Spiral Electrode tip breaking off, preventing easy removal from the scalp of the newborn infant.
Customers were advised to do the following:
* Visually examine the FSE upon removal from the newborn scalp to verify the tip is intact. If it is not intact, appropriate measures to locate and remove the missing part should be taken.
* Upon receipt of this notice, clinicians should review the following information from the device's Instructions for Use:
- Do not pull the Spiral Tip from the fetal skin. Do not pull the FSE wires
apart.
- Do not over-rotate Spiral Tip during attachment.
- Inspect the Spiral Tip to ensure that it is still attached to the FSE Hub. If
the tip has separated from the hub and remains embedded in the
presenting part, remove it using aseptic technique.
Customers were provided with a reply form and asked to complete the form and return it to Philips: 1-877-499-7223 (eFax) or email to
[email protected].
If you need any further information or support concerning this issue, please contact your local Philips representative: 1-800-722-9377, option 2.
Root Cause
Under Investigation by firm
Distribution Pattern
Distributed nationwide within US. Worldwide international distribution.
Related FDA 510(k) Records
Devices referenced by this recall via K-numbers.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement